These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8877260)

  • 1. Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial.
    Estacio RO; Savage S; Nagel NJ; Schrier RW
    Control Clin Trials; 1996 Jun; 17(3):242-57. PubMed ID: 8877260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
    Schrier RW; Estacio RO; Jeffers B
    Diabetologia; 1996 Dec; 39(12):1646-54. PubMed ID: 8960857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW; Estacio RO; Esler A; Mehler P
    Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
    Savage S; Johnson Nagel N; Estacio RO; Feig PU; MacCarthy EP; Lukken NJ; Ziegler R; Schrier RW
    Online J Curr Clin Trials; 1993 Nov; Doc No 104():[6250 words; 128 paragraphs]. PubMed ID: 8305994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
    Estacio RO; Schrier RW
    Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial in type 2 diabetic nephropathy.
    Lewis EJ; Hunsicker LG; Rodby RA;
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S191-4. PubMed ID: 11576953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
    Schrier RW; Estacio RO; Mehler PS; Hiatt WR
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):428-38. PubMed ID: 17653121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
    Gaede PH; Jepsen PV; Parving HH; Pedersen OB
    Ugeskr Laeger; 1999 Jul; 161(30):4277-85. PubMed ID: 10439688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the diabetes control and complications trial for persons with non-insulin-dependent diabetes mellitus.
    Vinik AI; Richardson DW
    South Med J; 1997 Mar; 90(3):268-82. PubMed ID: 9076296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes control and complications.
    Crofford OB
    Annu Rev Med; 1995; 46():267-79. PubMed ID: 7598463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and early detection of vascular complications of diabetes.
    Marshall SM; Flyvbjerg A
    BMJ; 2006 Sep; 333(7566):475-80. PubMed ID: 16946335
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
    Eastman RC; Siebert CW; Harris M; Gorden P
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.
    Bretzel RG; Bollen CC; Maeser E; Federlin KF
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):53-64. PubMed ID: 8503436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.